Regenosine, Inc - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $79,480.57 +3.78%
Ethereum $3,192.38 +4.98%
BNB $636.24 +0.91%
Optimism $1.68 +2.85%
Arbitrum $0.63 +4.61%
Solana $205.85 +1.87%
Polygon $0.40 +4.77%
Cosmos $5.12 +7.13%
Avalanche $31.84 +7.88%

Bitcoin $79,480.57 +3.78%
Ethereum $3,192.38 +4.98%
BNB $636.24 +0.91%
Optimism $1.68 +2.85%
Arbitrum $0.63 +4.61%
Solana $205.85 +1.87%
Polygon $0.40 +4.77%
Cosmos $5.12 +7.13%
Avalanche $31.84 +7.88%

Regenosine, Inc

company

Summary
Funding Rounds
Investors

About

Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis.

11 - 50

Highlights

Total Funding Amount

Details

Last Funding Type: Grant
Last Funding Money Raised: $1.67M
Industries: Biotechnology,Health Care,Pharmaceutical
Founded date: Jan 1, 2018
Number Of Employee: 11 - 50
Operating Status: Active

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

$1.67M

Regenosine, Inc has raised a total of $1.67M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2021 from a Grant round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 1, 2021	Grant	$1.67M	1	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	—	Detail

Investors

Number of Lead Investors

Number of Investors

1

1

Regenosine, Inc is funded by 1 investors. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) are the most recent investors.

Investor Name	Lead Investor	Funding Round
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Yes	Grant